

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.76028922 |
| 2 | fatty acid elongation (GO:0030497) | 6.72987395 |
| 3 | myelination (GO:0042552) | 6.62567507 |
| 4 | ensheathment of neurons (GO:0007272) | 6.62436363 |
| 5 | axon ensheathment (GO:0008366) | 6.62436363 |
| 6 | glutamate secretion (GO:0014047) | 6.52238744 |
| 7 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.77606518 |
| 8 | cellular potassium ion homeostasis (GO:0030007) | 5.57543054 |
| 9 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.37808416 |
| 10 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.01787259 |
| 11 | sodium ion export (GO:0071436) | 4.88998232 |
| 12 | neurotransmitter secretion (GO:0007269) | 4.78233508 |
| 13 | regulation of synaptic vesicle transport (GO:1902803) | 4.69066722 |
| 14 | negative regulation of neurotransmitter transport (GO:0051589) | 4.55588648 |
| 15 | myelin maintenance (GO:0043217) | 4.31726210 |
| 16 | potassium ion homeostasis (GO:0055075) | 4.26474758 |
| 17 | L-amino acid import (GO:0043092) | 4.23540101 |
| 18 | oligodendrocyte differentiation (GO:0048709) | 4.23349492 |
| 19 | glycerophospholipid catabolic process (GO:0046475) | 4.20731055 |
| 20 | postsynaptic membrane organization (GO:0001941) | 4.18630670 |
| 21 | vocalization behavior (GO:0071625) | 4.17462752 |
| 22 | potassium ion import (GO:0010107) | 4.17063843 |
| 23 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.15861161 |
| 24 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.12226655 |
| 25 | cholesterol biosynthetic process (GO:0006695) | 4.09560318 |
| 26 | positive regulation of synapse maturation (GO:0090129) | 4.06565065 |
| 27 | synaptic transmission, glutamatergic (GO:0035249) | 4.05410696 |
| 28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.03600545 |
| 29 | transmission of nerve impulse (GO:0019226) | 3.98444096 |
| 30 | establishment of mitochondrion localization (GO:0051654) | 3.96786729 |
| 31 | negative regulation of protein localization to cell surface (GO:2000009) | 3.96543364 |
| 32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.95704329 |
| 33 | substantia nigra development (GO:0021762) | 3.94699596 |
| 34 | positive regulation of dendritic spine development (GO:0060999) | 3.94372568 |
| 35 | neurotransmitter transport (GO:0006836) | 3.94154716 |
| 36 | presynaptic membrane organization (GO:0097090) | 3.91996586 |
| 37 | astrocyte development (GO:0014002) | 3.86643819 |
| 38 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.86087321 |
| 39 | creatine metabolic process (GO:0006600) | 3.85533261 |
| 40 | apical protein localization (GO:0045176) | 3.84946799 |
| 41 | regulation of collateral sprouting (GO:0048670) | 3.79079646 |
| 42 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.79038756 |
| 43 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.78456930 |
| 44 | exploration behavior (GO:0035640) | 3.78137262 |
| 45 | presynaptic membrane assembly (GO:0097105) | 3.77204002 |
| 46 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.75456305 |
| 47 | glutamate receptor signaling pathway (GO:0007215) | 3.73658957 |
| 48 | neuronal action potential propagation (GO:0019227) | 3.73391722 |
| 49 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.72933736 |
| 50 | asymmetric protein localization (GO:0008105) | 3.69993795 |
| 51 | regulation of neurotransmitter levels (GO:0001505) | 3.67828776 |
| 52 | adult walking behavior (GO:0007628) | 3.66203903 |
| 53 | protein localization to synapse (GO:0035418) | 3.61424827 |
| 54 | eye photoreceptor cell differentiation (GO:0001754) | 3.61317029 |
| 55 | photoreceptor cell differentiation (GO:0046530) | 3.61317029 |
| 56 | regulation of synaptic plasticity (GO:0048167) | 3.60961084 |
| 57 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.58219487 |
| 58 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.58210636 |
| 59 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.57503548 |
| 60 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.56955340 |
| 61 | sterol biosynthetic process (GO:0016126) | 3.56825456 |
| 62 | neuronal ion channel clustering (GO:0045161) | 3.53995905 |
| 63 | regulation of neurotransmitter secretion (GO:0046928) | 3.51720047 |
| 64 | acidic amino acid transport (GO:0015800) | 3.51079523 |
| 65 | adhesion of symbiont to host cell (GO:0044650) | 3.45051920 |
| 66 | virion attachment to host cell (GO:0019062) | 3.45051920 |
| 67 | neuromuscular process controlling balance (GO:0050885) | 3.44493302 |
| 68 | long-term synaptic potentiation (GO:0060291) | 3.43728861 |
| 69 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.42999477 |
| 70 | response to methylmercury (GO:0051597) | 3.42265825 |
| 71 | peripheral nervous system axon ensheathment (GO:0032292) | 3.40603552 |
| 72 | myelination in peripheral nervous system (GO:0022011) | 3.40603552 |
| 73 | regulation of synapse structural plasticity (GO:0051823) | 3.35521521 |
| 74 | regulation of neurotransmitter transport (GO:0051588) | 3.34151392 |
| 75 | synaptic vesicle maturation (GO:0016188) | 3.33709463 |
| 76 | regulation of dendritic spine development (GO:0060998) | 3.32705606 |
| 77 | membrane depolarization during action potential (GO:0086010) | 3.32007299 |
| 78 | regulation of synapse maturation (GO:0090128) | 3.31039731 |
| 79 | negative regulation of axonogenesis (GO:0050771) | 3.30566703 |
| 80 | regulation of postsynaptic membrane potential (GO:0060078) | 3.28690248 |
| 81 | cellular sodium ion homeostasis (GO:0006883) | 3.27963705 |
| 82 | phosphorelay signal transduction system (GO:0000160) | 3.26570362 |
| 83 | response to redox state (GO:0051775) | 3.23172065 |
| 84 | synaptic vesicle endocytosis (GO:0048488) | 3.22377243 |
| 85 | neuron cell-cell adhesion (GO:0007158) | 3.22151786 |
| 86 | negative regulation of inclusion body assembly (GO:0090084) | 3.19622032 |
| 87 | membrane tubulation (GO:0097320) | 3.19257351 |
| 88 | cell communication by electrical coupling (GO:0010644) | 3.19254440 |
| 89 | amyloid precursor protein metabolic process (GO:0042982) | 3.17048995 |
| 90 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.16368478 |
| 91 | isoprenoid biosynthetic process (GO:0008299) | 3.16296637 |
| 92 | L-glutamate transport (GO:0015813) | 3.15740530 |
| 93 | import into cell (GO:0098657) | 3.14234310 |
| 94 | regulation of ARF protein signal transduction (GO:0032012) | 3.14130048 |
| 95 | auditory behavior (GO:0031223) | 3.13725166 |
| 96 | positive regulation of action potential (GO:0045760) | 3.13695301 |
| 97 | amino acid import (GO:0043090) | 3.13030026 |
| 98 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.11159099 |
| 99 | membrane depolarization (GO:0051899) | 3.09437936 |
| 100 | regulation of synaptic transmission (GO:0050804) | 3.04879172 |
| 101 | regulation of vesicle fusion (GO:0031338) | 3.03578259 |
| 102 | protein palmitoylation (GO:0018345) | 3.03465690 |
| 103 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.01990796 |
| 104 | long-term memory (GO:0007616) | 3.01879702 |
| 105 | glycosylceramide metabolic process (GO:0006677) | 3.00167082 |
| 106 | positive regulation of dendrite development (GO:1900006) | 2.99540736 |
| 107 | synaptic transmission (GO:0007268) | 2.99215297 |
| 108 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.98622986 |
| 109 | dendritic spine morphogenesis (GO:0060997) | 2.96942411 |
| 110 | glycine transport (GO:0015816) | 2.96399291 |
| 111 | cerebellar granule cell differentiation (GO:0021707) | 2.96214651 |
| 112 | nerve growth factor signaling pathway (GO:0038180) | 2.95869331 |
| 113 | positive regulation of Rap GTPase activity (GO:0032854) | 2.95616010 |
| 114 | response to lipoprotein particle (GO:0055094) | 2.95253739 |
| 115 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.94799695 |
| 116 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.94577625 |
| 117 | neuromuscular synaptic transmission (GO:0007274) | 2.94446968 |
| 118 | cell differentiation in hindbrain (GO:0021533) | 2.92466386 |
| 119 | proline transport (GO:0015824) | 2.87998215 |
| 120 | neuromuscular process controlling posture (GO:0050884) | 2.87223539 |
| 121 | neuromuscular process (GO:0050905) | 2.87003323 |
| 122 | magnesium ion transport (GO:0015693) | 2.86593229 |
| 123 | cellular response to epinephrine stimulus (GO:0071872) | 2.86086034 |
| 124 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.84729709 |
| 125 | neurotransmitter catabolic process (GO:0042135) | 2.84506342 |
| 126 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.81179553 |
| 127 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.75280536 |
| 128 | gamma-aminobutyric acid transport (GO:0015812) | 2.74162758 |
| 129 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.73575898 |
| 130 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.72969897 |
| 131 | peptidyl-cysteine modification (GO:0018198) | 2.70560289 |
| 132 | negative regulation of axon extension (GO:0030517) | 2.70205417 |
| 133 | cyclic nucleotide catabolic process (GO:0009214) | 2.69826534 |
| 134 | axon development (GO:0061564) | 2.69294626 |
| 135 | negative regulation of JUN kinase activity (GO:0043508) | 2.68586597 |
| 136 | regulation of dopamine metabolic process (GO:0042053) | 2.67165735 |
| 137 | regulation of catecholamine metabolic process (GO:0042069) | 2.67165735 |
| 138 | synaptic vesicle exocytosis (GO:0016079) | 2.66807143 |
| 139 | locomotory exploration behavior (GO:0035641) | 2.64699281 |
| 140 | peripheral nervous system development (GO:0007422) | 2.64539621 |
| 141 | neural nucleus development (GO:0048857) | 2.64363685 |
| 142 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.62145950 |
| 143 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.61363928 |
| 144 | cellular response to catecholamine stimulus (GO:0071870) | 2.57307663 |
| 145 | cellular response to monoamine stimulus (GO:0071868) | 2.57307663 |
| 146 | membrane assembly (GO:0071709) | 2.55864917 |
| 147 | mating behavior (GO:0007617) | 2.54914040 |
| 148 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.53421480 |
| 149 | neurotransmitter uptake (GO:0001504) | 2.53261175 |
| 150 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.52954130 |
| 151 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.52592051 |
| 152 | response to epinephrine (GO:0071871) | 2.52455614 |
| 153 | neuron remodeling (GO:0016322) | 2.51915105 |
| 154 | positive regulation of membrane potential (GO:0045838) | 2.51638866 |
| 155 | Golgi to endosome transport (GO:0006895) | 2.50898459 |
| 156 | neuron-neuron synaptic transmission (GO:0007270) | 2.50715417 |
| 157 | very long-chain fatty acid metabolic process (GO:0000038) | 2.49008646 |
| 158 | neuron recognition (GO:0008038) | 2.48787188 |
| 159 | adult locomotory behavior (GO:0008344) | 2.47988058 |
| 160 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.47847776 |
| 161 | adhesion of symbiont to host (GO:0044406) | 2.45696046 |
| 162 | central nervous system myelination (GO:0022010) | 10.0485605 |
| 163 | axon ensheathment in central nervous system (GO:0032291) | 10.0485605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.38325861 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.08380913 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.69374883 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.69266985 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.63093824 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.37247943 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.37247943 |
| 8 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35941522 |
| 9 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.32225670 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.28287538 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.26152189 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.24838432 |
| 13 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.24319533 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.23440132 |
| 15 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13567384 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.12987065 |
| 17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.12391596 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.11189273 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.10079230 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.09252554 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.06580401 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.99564248 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87085145 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.86672444 |
| 25 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.75851454 |
| 26 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.73648403 |
| 27 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.72823118 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70049153 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.69450136 |
| 30 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.55351345 |
| 31 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.52698498 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.51667879 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.48973489 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47881972 |
| 35 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.46861401 |
| 36 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46210845 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44928800 |
| 38 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.41749085 |
| 39 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.40121918 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39990844 |
| 41 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.38097076 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37588156 |
| 43 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.37041563 |
| 44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.35959605 |
| 45 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.29778455 |
| 46 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.29075607 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28599242 |
| 48 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27915763 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.26016479 |
| 50 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.25421010 |
| 51 | VDR_22108803_ChIP-Seq_LS180_Human | 1.25137862 |
| 52 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24777698 |
| 53 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.23322694 |
| 54 | AR_19668381_ChIP-Seq_PC3_Human | 1.22805182 |
| 55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.21521894 |
| 56 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.20842978 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20222766 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.19011553 |
| 59 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.15350045 |
| 60 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15173697 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12671650 |
| 62 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11898886 |
| 63 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11608607 |
| 64 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11227249 |
| 65 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08784167 |
| 66 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07360071 |
| 67 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06318052 |
| 68 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05200391 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04509492 |
| 70 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.04232179 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04127205 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.04123338 |
| 73 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.03615010 |
| 74 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.03156396 |
| 75 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.02150248 |
| 76 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01808885 |
| 77 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01537459 |
| 78 | FUS_26573619_Chip-Seq_HEK293_Human | 1.01491903 |
| 79 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00436638 |
| 80 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00334293 |
| 81 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.99315222 |
| 82 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98772829 |
| 83 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98671164 |
| 84 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98063865 |
| 85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97641653 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97641653 |
| 87 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.97403916 |
| 88 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.96520442 |
| 89 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96434583 |
| 90 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96172336 |
| 91 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95445243 |
| 92 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.95213815 |
| 93 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95057204 |
| 94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.94621626 |
| 95 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94534130 |
| 96 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.94327727 |
| 97 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94098256 |
| 98 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93759164 |
| 99 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93755662 |
| 100 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93618174 |
| 101 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92931785 |
| 102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92505684 |
| 103 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92233881 |
| 104 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92228360 |
| 105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91729218 |
| 106 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91349436 |
| 107 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.91223965 |
| 108 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91053516 |
| 109 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90334663 |
| 110 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90334633 |
| 111 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.90324972 |
| 112 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89977969 |
| 113 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.89525046 |
| 114 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89331212 |
| 115 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.89312415 |
| 116 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88849133 |
| 117 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88076321 |
| 118 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88014633 |
| 119 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88014633 |
| 120 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.87939526 |
| 121 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87181466 |
| 122 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.86535050 |
| 123 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86212208 |
| 124 | TBL1_22424771_ChIP-Seq_293T_Human | 0.85319779 |
| 125 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85076991 |
| 126 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84908545 |
| 127 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.84887921 |
| 128 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84502166 |
| 129 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.84271357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0000920_abnormal_myelination | 4.69514476 |
| 2 | MP0003880_abnormal_central_pattern | 4.62945476 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.04046244 |
| 4 | MP0004270_analgesia | 3.86138078 |
| 5 | MP0003690_abnormal_glial_cell | 3.17151432 |
| 6 | MP0002272_abnormal_nervous_system | 2.90321869 |
| 7 | MP0001486_abnormal_startle_reflex | 2.85172542 |
| 8 | MP0002064_seizures | 2.84872330 |
| 9 | MP0004885_abnormal_endolymph | 2.80294110 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 2.74039911 |
| 11 | MP0003329_amyloid_beta_deposits | 2.74021069 |
| 12 | MP0001529_abnormal_vocalization | 2.70698955 |
| 13 | MP0009046_muscle_twitch | 2.57860093 |
| 14 | MP0009745_abnormal_behavioral_response | 2.57260969 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.50076768 |
| 16 | MP0001905_abnormal_dopamine_level | 2.43554812 |
| 17 | MP0002822_catalepsy | 2.35084570 |
| 18 | MP0004742_abnormal_vestibular_system | 2.33580242 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.32368686 |
| 20 | MP0004142_abnormal_muscle_tone | 2.24809528 |
| 21 | MP0003634_abnormal_glial_cell | 2.21702531 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 2.13419044 |
| 23 | MP0001485_abnormal_pinna_reflex | 2.11587254 |
| 24 | MP0000778_abnormal_nervous_system | 2.06725799 |
| 25 | MP0002063_abnormal_learning/memory/cond | 2.05299371 |
| 26 | MP0003879_abnormal_hair_cell | 1.96658160 |
| 27 | MP0005409_darkened_coat_color | 1.94612922 |
| 28 | MP0002572_abnormal_emotion/affect_behav | 1.90077731 |
| 29 | MP0005171_absent_coat_pigmentation | 1.86730440 |
| 30 | MP0002229_neurodegeneration | 1.84813226 |
| 31 | MP0003632_abnormal_nervous_system | 1.77614290 |
| 32 | MP0003787_abnormal_imprinting | 1.70896987 |
| 33 | MP0001440_abnormal_grooming_behavior | 1.70508350 |
| 34 | MP0008569_lethality_at_weaning | 1.68302358 |
| 35 | MP0000955_abnormal_spinal_cord | 1.66232293 |
| 36 | MP0005410_abnormal_fertilization | 1.54190036 |
| 37 | MP0002882_abnormal_neuron_morphology | 1.52465088 |
| 38 | MP0003136_yellow_coat_color | 1.52114542 |
| 39 | MP0004924_abnormal_behavior | 1.51144547 |
| 40 | MP0005386_behavior/neurological_phenoty | 1.51144547 |
| 41 | MP0005451_abnormal_body_composition | 1.47674630 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.47162636 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.47034693 |
| 44 | MP0001970_abnormal_pain_threshold | 1.46734020 |
| 45 | MP0003631_nervous_system_phenotype | 1.46136839 |
| 46 | MP0000604_amyloidosis | 1.40042996 |
| 47 | MP0001968_abnormal_touch/_nociception | 1.37622369 |
| 48 | MP0004043_abnormal_pH_regulation | 1.36029592 |
| 49 | MP0003633_abnormal_nervous_system | 1.35772935 |
| 50 | MP0002733_abnormal_thermal_nociception | 1.33175566 |
| 51 | MP0010678_abnormal_skin_adnexa | 1.31614455 |
| 52 | MP0005551_abnormal_eye_electrophysiolog | 1.30595802 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 1.29521551 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.28280900 |
| 55 | MP0000462_abnormal_digestive_system | 1.24811335 |
| 56 | MP0001963_abnormal_hearing_physiology | 1.16189716 |
| 57 | MP0000747_muscle_weakness | 1.09499630 |
| 58 | MP0004147_increased_porphyrin_level | 1.08525133 |
| 59 | MP0001299_abnormal_eye_distance/ | 1.08223786 |
| 60 | MP0002752_abnormal_somatic_nervous | 1.07784087 |
| 61 | MP0005623_abnormal_meninges_morphology | 1.06672388 |
| 62 | MP0000383_abnormal_hair_follicle | 1.06142598 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.05229096 |
| 64 | MP0001177_atelectasis | 1.02515672 |
| 65 | MP0002736_abnormal_nociception_after | 1.01045452 |
| 66 | MP0000569_abnormal_digit_pigmentation | 0.99896031 |
| 67 | MP0002557_abnormal_social/conspecific_i | 0.98823670 |
| 68 | MP0002152_abnormal_brain_morphology | 0.97489858 |
| 69 | MP0002735_abnormal_chemical_nociception | 0.96446840 |
| 70 | MP0003122_maternal_imprinting | 0.95498350 |
| 71 | MP0003123_paternal_imprinting | 0.95276729 |
| 72 | MP0000566_synostosis | 0.93646022 |
| 73 | MP0002184_abnormal_innervation | 0.93638439 |
| 74 | MP0004134_abnormal_chest_morphology | 0.90814933 |
| 75 | MP0005058_abnormal_lysosome_morphology | 0.89904648 |
| 76 | MP0001346_abnormal_lacrimal_gland | 0.88793026 |
| 77 | MP0008877_abnormal_DNA_methylation | 0.85496465 |
| 78 | MP0003195_calcinosis | 0.85120164 |
| 79 | MP0002638_abnormal_pupillary_reflex | 0.84597593 |
| 80 | MP0004381_abnormal_hair_follicle | 0.84516000 |
| 81 | MP0003806_abnormal_nucleotide_metabolis | 0.83597691 |
| 82 | MP0004145_abnormal_muscle_electrophysio | 0.82148114 |
| 83 | MP0005646_abnormal_pituitary_gland | 0.80998853 |
| 84 | MP0001986_abnormal_taste_sensitivity | 0.79984102 |
| 85 | MP0001502_abnormal_circadian_rhythm | 0.79432377 |
| 86 | MP0003075_altered_response_to | 0.77688180 |
| 87 | MP0008260_abnormal_autophagy | 0.77485817 |
| 88 | MP0002090_abnormal_vision | 0.75524349 |
| 89 | MP0008874_decreased_physiological_sensi | 0.73890060 |
| 90 | MP0003938_abnormal_ear_development | 0.73103180 |
| 91 | MP0005195_abnormal_posterior_eye | 0.72248374 |
| 92 | MP0001851_eye_inflammation | 0.71548479 |
| 93 | MP0008872_abnormal_physiological_respon | 0.71535162 |
| 94 | MP0003045_fibrosis | 0.71214712 |
| 95 | MP0006072_abnormal_retinal_apoptosis | 0.70713019 |
| 96 | MP0001661_extended_life_span | 0.70022719 |
| 97 | MP0009780_abnormal_chondrocyte_physiolo | 0.69308058 |
| 98 | MP0003137_abnormal_impulse_conducting | 0.68080836 |
| 99 | MP0002909_abnormal_adrenal_gland | 0.67572972 |
| 100 | MP0000026_abnormal_inner_ear | 0.65556312 |
| 101 | MP0005253_abnormal_eye_physiology | 0.64119136 |
| 102 | MP0000579_abnormal_nail_morphology | 0.64091164 |
| 103 | MP0010386_abnormal_urinary_bladder | 0.63163492 |
| 104 | MP0005645_abnormal_hypothalamus_physiol | 0.61981313 |
| 105 | MP0000647_abnormal_sebaceous_gland | 0.61589804 |
| 106 | MP0005535_abnormal_body_temperature | 0.60112325 |
| 107 | MP0001984_abnormal_olfaction | 0.59969435 |
| 108 | MP0004130_abnormal_muscle_cell | 0.59301436 |
| 109 | MP0001348_abnormal_lacrimal_gland | 0.58672899 |
| 110 | MP0002069_abnormal_eating/drinking_beha | 0.57453461 |
| 111 | MP0002295_abnormal_pulmonary_circulatio | 0.57363676 |
| 112 | MP0004085_abnormal_heartbeat | 0.56652035 |
| 113 | MP0010769_abnormal_survival | 0.54997507 |
| 114 | MP0001943_abnormal_respiration | 0.54813395 |
| 115 | MP0004036_abnormal_muscle_relaxation | 0.54378214 |
| 116 | MP0001727_abnormal_embryo_implantation | 0.52936694 |
| 117 | MP0006276_abnormal_autonomic_nervous | 0.52201541 |
| 118 | MP0002082_postnatal_lethality | 0.51762186 |
| 119 | MP0010770_preweaning_lethality | 0.51762186 |
| 120 | MP0010768_mortality/aging | 0.51301323 |
| 121 | MP0000467_abnormal_esophagus_morphology | 0.50945243 |
| 122 | MP0004215_abnormal_myocardial_fiber | 0.47058243 |
| 123 | MP0000639_abnormal_adrenal_gland | 0.44995888 |
| 124 | MP0002089_abnormal_postnatal_growth/wei | 0.44820901 |
| 125 | MP0003956_abnormal_body_size | 0.44738132 |
| 126 | MP0000631_abnormal_neuroendocrine_gland | 0.44020965 |
| 127 | MP0003861_abnormal_nervous_system | 0.43040794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.25190392 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.25190392 |
| 3 | Neurofibrillary tangles (HP:0002185) | 6.20664441 |
| 4 | Febrile seizures (HP:0002373) | 5.06270157 |
| 5 | Abnormality of the corticospinal tract (HP:0002492) | 4.89284110 |
| 6 | Sensory axonal neuropathy (HP:0003390) | 4.83305415 |
| 7 | Diplopia (HP:0000651) | 4.73014840 |
| 8 | Abnormality of binocular vision (HP:0011514) | 4.73014840 |
| 9 | Myokymia (HP:0002411) | 4.70872618 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 4.53164574 |
| 11 | Cerebral inclusion bodies (HP:0100314) | 4.51858910 |
| 12 | Peripheral hypomyelination (HP:0007182) | 4.44220561 |
| 13 | Parakeratosis (HP:0001036) | 4.44196704 |
| 14 | Spastic gait (HP:0002064) | 4.10227082 |
| 15 | Intention tremor (HP:0002080) | 3.97785581 |
| 16 | Cerebral hypomyelination (HP:0006808) | 3.81414666 |
| 17 | Dysmetria (HP:0001310) | 3.80052706 |
| 18 | Onion bulb formation (HP:0003383) | 3.79991456 |
| 19 | Generalized tonic-clonic seizures (HP:0002069) | 3.64254170 |
| 20 | Abnormal eating behavior (HP:0100738) | 3.55826095 |
| 21 | Focal motor seizures (HP:0011153) | 3.47923127 |
| 22 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.47695187 |
| 23 | Ankle clonus (HP:0011448) | 3.40547950 |
| 24 | Scanning speech (HP:0002168) | 3.35408696 |
| 25 | Visual hallucinations (HP:0002367) | 3.25233241 |
| 26 | Termporal pattern (HP:0011008) | 3.24100512 |
| 27 | Insidious onset (HP:0003587) | 3.24100512 |
| 28 | Akinesia (HP:0002304) | 3.20460619 |
| 29 | Slow saccadic eye movements (HP:0000514) | 3.14207866 |
| 30 | Abnormal auditory evoked potentials (HP:0006958) | 3.05200489 |
| 31 | Hemiplegia (HP:0002301) | 2.97727361 |
| 32 | Hemiparesis (HP:0001269) | 2.97318098 |
| 33 | Limb dystonia (HP:0002451) | 2.96277428 |
| 34 | Papilledema (HP:0001085) | 2.94367183 |
| 35 | Truncal ataxia (HP:0002078) | 2.91030205 |
| 36 | Alacrima (HP:0000522) | 2.86880998 |
| 37 | Torticollis (HP:0000473) | 2.80067484 |
| 38 | Action tremor (HP:0002345) | 2.76937354 |
| 39 | Obstructive sleep apnea (HP:0002870) | 2.75861616 |
| 40 | Atonic seizures (HP:0010819) | 2.70692923 |
| 41 | Increased circulating renin level (HP:0000848) | 2.70183110 |
| 42 | Leukodystrophy (HP:0002415) | 2.70151876 |
| 43 | Epileptiform EEG discharges (HP:0011182) | 2.67654655 |
| 44 | Retinal dysplasia (HP:0007973) | 2.64841084 |
| 45 | Abnormality of glycolysis (HP:0004366) | 2.64350279 |
| 46 | Increased serum pyruvate (HP:0003542) | 2.64350279 |
| 47 | Spastic paraparesis (HP:0002313) | 2.63126526 |
| 48 | Status epilepticus (HP:0002133) | 2.60724042 |
| 49 | Bundle branch block (HP:0011710) | 2.60526372 |
| 50 | Mutism (HP:0002300) | 2.60076418 |
| 51 | Focal seizures (HP:0007359) | 2.52183028 |
| 52 | Tetraplegia (HP:0002445) | 2.51998552 |
| 53 | Poor eye contact (HP:0000817) | 2.51904689 |
| 54 | Thickened helices (HP:0000391) | 2.50464284 |
| 55 | Delusions (HP:0000746) | 2.50352887 |
| 56 | Pheochromocytoma (HP:0002666) | 2.50238192 |
| 57 | Sleep apnea (HP:0010535) | 2.46953854 |
| 58 | Lower limb muscle weakness (HP:0007340) | 2.43700987 |
| 59 | Cerebral hemorrhage (HP:0001342) | 2.42268921 |
| 60 | Epileptic encephalopathy (HP:0200134) | 2.42093007 |
| 61 | Megalencephaly (HP:0001355) | 2.42085055 |
| 62 | Bradykinesia (HP:0002067) | 2.41822671 |
| 63 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.40904818 |
| 64 | CNS hypomyelination (HP:0003429) | 2.40582900 |
| 65 | Annular pancreas (HP:0001734) | 2.37100519 |
| 66 | Anteriorly placed anus (HP:0001545) | 2.36554171 |
| 67 | Spastic tetraparesis (HP:0001285) | 2.35680303 |
| 68 | Depression (HP:0000716) | 2.33063757 |
| 69 | Focal dystonia (HP:0004373) | 2.30623229 |
| 70 | Clonus (HP:0002169) | 2.30603441 |
| 71 | Urinary urgency (HP:0000012) | 2.30558512 |
| 72 | Hypoplastic pelvis (HP:0008839) | 2.30088268 |
| 73 | EEG with generalized epileptiform discharges (HP:0011198) | 2.27234800 |
| 74 | Rigidity (HP:0002063) | 2.24646363 |
| 75 | Morphological abnormality of the inner ear (HP:0011390) | 2.23543295 |
| 76 | Autoamputation (HP:0001218) | 2.23407127 |
| 77 | Dysdiadochokinesis (HP:0002075) | 2.23315419 |
| 78 | Hyperventilation (HP:0002883) | 2.23017206 |
| 79 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.20941306 |
| 80 | Decreased lacrimation (HP:0000633) | 2.19198784 |
| 81 | Apathy (HP:0000741) | 2.17011246 |
| 82 | Clumsiness (HP:0002312) | 2.16804237 |
| 83 | Impaired smooth pursuit (HP:0007772) | 2.16658933 |
| 84 | Neuroendocrine neoplasm (HP:0100634) | 2.16117913 |
| 85 | Absent septum pellucidum (HP:0001331) | 2.14967844 |
| 86 | Craniofacial dystonia (HP:0012179) | 2.13816898 |
| 87 | Abnormality of the periventricular white matter (HP:0002518) | 2.13596991 |
| 88 | Insomnia (HP:0100785) | 2.13474935 |
| 89 | Metabolic alkalosis (HP:0200114) | 2.13365464 |
| 90 | Gaze-evoked nystagmus (HP:0000640) | 2.12652407 |
| 91 | Stridor (HP:0010307) | 2.10840056 |
| 92 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.10347913 |
| 93 | Premature skin wrinkling (HP:0100678) | 2.10067788 |
| 94 | Genetic anticipation (HP:0003743) | 2.09621815 |
| 95 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.09430097 |
| 96 | Aplasia of the phalanges of the hand (HP:0009802) | 2.09430097 |
| 97 | Aplasia involving bones of the extremities (HP:0009825) | 2.09430097 |
| 98 | Hypsarrhythmia (HP:0002521) | 2.09160328 |
| 99 | Spastic paraplegia (HP:0001258) | 2.09072792 |
| 100 | Paraplegia (HP:0010550) | 2.09044902 |
| 101 | Abnormal social behavior (HP:0012433) | 2.08891861 |
| 102 | Impaired social interactions (HP:0000735) | 2.08891861 |
| 103 | Polyphagia (HP:0002591) | 2.08845505 |
| 104 | Absent speech (HP:0001344) | 2.06665026 |
| 105 | Hypomagnesemia (HP:0002917) | 2.06095028 |
| 106 | Bowel incontinence (HP:0002607) | 2.05396208 |
| 107 | Impaired vibratory sensation (HP:0002495) | 2.05322516 |
| 108 | Generalized myoclonic seizures (HP:0002123) | 2.04938975 |
| 109 | Amblyopia (HP:0000646) | 2.02539678 |
| 110 | Split foot (HP:0001839) | 2.02205758 |
| 111 | Urinary incontinence (HP:0000020) | 2.00709352 |
| 112 | Broad-based gait (HP:0002136) | 2.00555630 |
| 113 | Abnormality of saccadic eye movements (HP:0000570) | 1.98789308 |
| 114 | Rapidly progressive (HP:0003678) | 1.97648400 |
| 115 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.97070540 |
| 116 | Anxiety (HP:0000739) | 1.93196389 |
| 117 | Progressive cerebellar ataxia (HP:0002073) | 1.93076608 |
| 118 | Partial agenesis of the corpus callosum (HP:0001338) | 1.92369521 |
| 119 | Dialeptic seizures (HP:0011146) | 1.92316274 |
| 120 | Diminished motivation (HP:0000745) | 1.92159922 |
| 121 | Foot dorsiflexor weakness (HP:0009027) | 1.92075316 |
| 122 | Hammertoe (HP:0001765) | 1.91806708 |
| 123 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.91619919 |
| 124 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.91483543 |
| 125 | Poor speech (HP:0002465) | 1.90531164 |
| 126 | Infantile muscular hypotonia (HP:0008947) | 1.90484108 |
| 127 | Hypokalemic alkalosis (HP:0001949) | 1.89926713 |
| 128 | Abnormal large intestine physiology (HP:0012700) | 1.89492421 |
| 129 | Abnormality of the lower motor neuron (HP:0002366) | 1.88700344 |
| 130 | Coronal craniosynostosis (HP:0004440) | 1.87643618 |
| 131 | Distal sensory impairment (HP:0002936) | 1.86709487 |
| 132 | Neuronal loss in central nervous system (HP:0002529) | 1.86687281 |
| 133 | Decreased motor nerve conduction velocity (HP:0003431) | 1.86495108 |
| 134 | Drooling (HP:0002307) | 1.83685910 |
| 135 | Paraparesis (HP:0002385) | 1.83661567 |
| 136 | Progressive inability to walk (HP:0002505) | 1.82949611 |
| 137 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.82619566 |
| 138 | Postural instability (HP:0002172) | 1.82382453 |
| 139 | Choreoathetosis (HP:0001266) | 1.82366624 |
| 140 | Methylmalonic acidemia (HP:0002912) | 1.81966381 |
| 141 | Abnormality of the septum pellucidum (HP:0007375) | 1.78707375 |
| 142 | Diminished movement (HP:0002374) | 1.75229116 |
| 143 | Relative macrocephaly (HP:0004482) | 1.75171435 |
| 144 | Hepatosplenomegaly (HP:0001433) | 1.74677880 |
| 145 | Cupped ear (HP:0000378) | 1.74439649 |
| 146 | Abnormality of the foot musculature (HP:0001436) | 1.73704753 |
| 147 | Absence seizures (HP:0002121) | 1.73601480 |
| 148 | Synostosis involving the elbow (HP:0003938) | 1.72993838 |
| 149 | Humeroradial synostosis (HP:0003041) | 1.72993838 |
| 150 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.72801187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.68001438 |
| 2 | OXSR1 | 4.24845194 |
| 3 | EPHA4 | 2.83670748 |
| 4 | TNIK | 2.83322306 |
| 5 | CDK19 | 2.78035903 |
| 6 | EPHB1 | 2.71419838 |
| 7 | BCR | 2.60543198 |
| 8 | WNK4 | 2.37402199 |
| 9 | WNK1 | 2.33930707 |
| 10 | UHMK1 | 2.28052271 |
| 11 | PKN1 | 2.10293019 |
| 12 | NEK6 | 1.96433542 |
| 13 | PAK6 | 1.95617435 |
| 14 | MAPKAPK5 | 1.93564949 |
| 15 | PBK | 1.90481551 |
| 16 | MET | 1.89970790 |
| 17 | PRPF4B | 1.88882400 |
| 18 | NTRK1 | 1.84444497 |
| 19 | ICK | 1.83244205 |
| 20 | RIPK4 | 1.79209802 |
| 21 | LIMK1 | 1.71392923 |
| 22 | PLK2 | 1.71348199 |
| 23 | FGFR2 | 1.69104940 |
| 24 | CSNK1G3 | 1.68903808 |
| 25 | CSNK1A1L | 1.62951438 |
| 26 | PNCK | 1.62737379 |
| 27 | CAMK2B | 1.45614506 |
| 28 | CSNK1G2 | 1.43832694 |
| 29 | ROCK2 | 1.39774603 |
| 30 | MARK1 | 1.36494398 |
| 31 | MAP3K9 | 1.35334127 |
| 32 | KSR2 | 1.29334813 |
| 33 | FGR | 1.27620553 |
| 34 | TYRO3 | 1.24272350 |
| 35 | CSNK1G1 | 1.23809085 |
| 36 | ARAF | 1.20924823 |
| 37 | SGK2 | 1.19570944 |
| 38 | CLK1 | 1.19295377 |
| 39 | SGK223 | 1.19156338 |
| 40 | SGK494 | 1.19156338 |
| 41 | CAMK2D | 1.18033375 |
| 42 | CDK5 | 1.14555233 |
| 43 | NTRK3 | 1.14196613 |
| 44 | CAMKK2 | 1.07625407 |
| 45 | CDK14 | 1.05972218 |
| 46 | DAPK1 | 1.01749638 |
| 47 | TESK2 | 1.01158485 |
| 48 | SGK3 | 0.97371561 |
| 49 | CDK15 | 0.96273874 |
| 50 | CAMK2G | 0.95490004 |
| 51 | MAP3K13 | 0.94956233 |
| 52 | MARK2 | 0.92203013 |
| 53 | CDK18 | 0.90997936 |
| 54 | LATS2 | 0.90852457 |
| 55 | PAK3 | 0.90501031 |
| 56 | CDK11A | 0.87003676 |
| 57 | MINK1 | 0.86335057 |
| 58 | CAMK2A | 0.86127291 |
| 59 | PRKD3 | 0.85828131 |
| 60 | NTRK2 | 0.85572275 |
| 61 | RIPK1 | 0.84961393 |
| 62 | STK38 | 0.84527000 |
| 63 | PRKCQ | 0.82053306 |
| 64 | * MAPK10 | 0.81809122 |
| 65 | MAPK12 | 0.80653057 |
| 66 | MST4 | 0.79131662 |
| 67 | PDPK1 | 0.78171779 |
| 68 | CASK | 0.75421309 |
| 69 | RPS6KA3 | 0.74404095 |
| 70 | PINK1 | 0.72222419 |
| 71 | SIK2 | 0.71880445 |
| 72 | PRKD1 | 0.71743388 |
| 73 | PRKCH | 0.69100775 |
| 74 | PHKG2 | 0.68085378 |
| 75 | PHKG1 | 0.68085378 |
| 76 | STK11 | 0.66403860 |
| 77 | MAP3K2 | 0.66401782 |
| 78 | FES | 0.66304425 |
| 79 | FYN | 0.65530021 |
| 80 | TNK2 | 0.63362065 |
| 81 | MAP3K4 | 0.63350928 |
| 82 | CAMK4 | 0.61365623 |
| 83 | MUSK | 0.61198213 |
| 84 | MAP3K11 | 0.60723159 |
| 85 | PRKCZ | 0.60404395 |
| 86 | PRKCE | 0.57535751 |
| 87 | MAP2K4 | 0.55949848 |
| 88 | MAPK15 | 0.53711237 |
| 89 | KSR1 | 0.52416414 |
| 90 | DAPK2 | 0.51978040 |
| 91 | IRAK2 | 0.50616240 |
| 92 | PDK1 | 0.47109082 |
| 93 | MAPK13 | 0.46529436 |
| 94 | DYRK2 | 0.46191046 |
| 95 | CSNK1D | 0.45195406 |
| 96 | DAPK3 | 0.44998845 |
| 97 | BRSK1 | 0.44167957 |
| 98 | PRKCA | 0.42820976 |
| 99 | CSNK1A1 | 0.42188503 |
| 100 | PRKG1 | 0.41323867 |
| 101 | ERBB4 | 0.39738566 |
| 102 | PRKCG | 0.38354154 |
| 103 | BMX | 0.37999318 |
| 104 | GRK5 | 0.37084380 |
| 105 | PRKCB | 0.37020145 |
| 106 | ERBB2 | 0.36805503 |
| 107 | PRKACB | 0.36441735 |
| 108 | RET | 0.34271254 |
| 109 | CAMK1G | 0.33905320 |
| 110 | SGK1 | 0.31860983 |
| 111 | MAP2K7 | 0.31817816 |
| 112 | MAPK7 | 0.31660349 |
| 113 | PTK2B | 0.31508615 |
| 114 | DDR2 | 0.31079066 |
| 115 | ROCK1 | 0.28880299 |
| 116 | PAK1 | 0.28761260 |
| 117 | PRKACA | 0.28560164 |
| 118 | BMPR2 | 0.28298128 |
| 119 | MOS | 0.27930989 |
| 120 | DYRK1A | 0.27523415 |
| 121 | DMPK | 0.27399723 |
| 122 | CAMK1 | 0.27341713 |
| 123 | PDGFRB | 0.27317909 |
| 124 | CAMKK1 | 0.26797288 |
| 125 | ALK | 0.26524957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.73699505 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.81615531 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.53947383 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.07098694 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.64908444 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.21878991 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.21545420 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.11283860 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.97942177 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.97332299 |
| 11 | Axon guidance_Homo sapiens_hsa04360 | 1.88422310 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 1.80664014 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.72998101 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.69920097 |
| 15 | Nicotine addiction_Homo sapiens_hsa05033 | 1.69004757 |
| 16 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.65450275 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.57796053 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.57309435 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.57006099 |
| 20 | Circadian entrainment_Homo sapiens_hsa04713 | 1.56104455 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.51877186 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.41932022 |
| 23 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.40871932 |
| 24 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.40364678 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39776123 |
| 26 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.35592091 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.30385149 |
| 28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.28774676 |
| 29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.26775033 |
| 30 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.24347337 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.23840625 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.22642481 |
| 33 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.17400000 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.17382884 |
| 35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.17138226 |
| 36 | Alzheimers disease_Homo sapiens_hsa05010 | 1.17074889 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15605265 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14739463 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.13559697 |
| 40 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.11685622 |
| 41 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.11570059 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.07750236 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 1.07266835 |
| 44 | Protein export_Homo sapiens_hsa03060 | 1.04900876 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.03292914 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.02352616 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99751469 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99227162 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98457668 |
| 50 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.97846251 |
| 51 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95636788 |
| 52 | Endocytosis_Homo sapiens_hsa04144 | 0.93632618 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.92917267 |
| 54 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89699708 |
| 55 | Tight junction_Homo sapiens_hsa04530 | 0.89490316 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87511147 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86947939 |
| 58 | Glioma_Homo sapiens_hsa05214 | 0.85422475 |
| 59 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.83830024 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83284729 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83121391 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 0.82709503 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82405561 |
| 64 | Gap junction_Homo sapiens_hsa04540 | 0.80373974 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80302301 |
| 66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.80113618 |
| 67 | Histidine metabolism_Homo sapiens_hsa00340 | 0.79586875 |
| 68 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.77106446 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76801853 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.76691535 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75980148 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 0.74943805 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.73172768 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72736513 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72317415 |
| 76 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.72134985 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.71610253 |
| 78 | Phototransduction_Homo sapiens_hsa04744 | 0.71171710 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70645191 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70171112 |
| 81 | Insulin secretion_Homo sapiens_hsa04911 | 0.69556898 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67338338 |
| 83 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67057855 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.65063709 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63123004 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60355242 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59919717 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58585016 |
| 89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.58120231 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56862260 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56120524 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55457962 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55032118 |
| 94 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52464850 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52244662 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50641867 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.49285922 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.49234117 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48933993 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48107375 |
| 101 | Alcoholism_Homo sapiens_hsa05034 | 0.46838168 |
| 102 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46792631 |
| 103 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46088798 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44752457 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43505508 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.43296344 |
| 107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43146997 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.42951439 |
| 109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40935046 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.40431799 |
| 111 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.40004050 |
| 112 | Melanogenesis_Homo sapiens_hsa04916 | 0.39498230 |
| 113 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39083636 |
| 114 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.38776967 |
| 115 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38720371 |
| 116 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.36935632 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35843508 |
| 118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35137108 |
| 119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34783382 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34039458 |
| 121 | Phagosome_Homo sapiens_hsa04145 | 0.33614863 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33084045 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32944666 |
| 124 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32097810 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.31547782 |
| 126 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.29135924 |
| 127 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27314134 |
| 128 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.25283643 |

